Methimazole is a prescription medication used to treat hyperthyroidism, a condition where the thyroid gland produces too much thyroid hormone. It’s the most commonly prescribed antithyroid drug in the United States and is also used to stabilize thyroid levels before thyroid surgery or radioactive iodine treatment. Sold under the brand name Tapazole, methimazole works by slowing down the thyroid’s ability to manufacture hormones, bringing levels back to a normal range over several weeks.
How Methimazole Works
Your thyroid gland needs iodine to build its hormones, known as T3 and T4. Methimazole interferes with this process in two ways. First, it blocks the activity of a key enzyme called thyroid peroxidase, which is responsible for attaching iodine to the protein that becomes thyroid hormone. Second, it traps iodine directly by forming chemical complexes with it, making less iodine available for hormone production. Both of these effects reduce the amount of thyroid hormone your body makes and releases into the bloodstream.
Methimazole doesn’t destroy thyroid tissue or remove existing hormone that’s already circulating. It only prevents new hormone from being made. That’s why it takes time to work. Most people notice improvement within a few weeks, but it can take one to two months for thyroid levels to reach a normal range.
Conditions Methimazole Treats
The primary use of methimazole is treating hyperthyroidism, regardless of the underlying cause. Graves’ disease, an autoimmune condition where antibodies overstimulate the thyroid, is the most common reason it’s prescribed. It’s also used for toxic multinodular goiter and other forms of overactive thyroid.
Beyond long-term management, methimazole plays an important role in preparing patients for thyroid surgery or radioactive iodine therapy. Operating on a thyroid that’s pumping out excess hormone carries significant risks, including a dangerous spike in thyroid hormone levels during or after the procedure. Taking methimazole beforehand brings hormone levels into a safe range. One approach, called “block and replace,” combines a medium dose of methimazole with a synthetic thyroid hormone supplement. This method achieved normal thyroid levels in about 87% of patients before surgery, compared to roughly 47% with methimazole alone.
What to Expect During Treatment
Dosing depends on how overactive your thyroid is. For mild hyperthyroidism, a typical starting dose is 15 mg per day. Moderate cases usually call for 30 to 40 mg per day, and severe cases may require up to 60 mg per day, split into multiple doses throughout the day. Once thyroid levels normalize, your doctor will gradually reduce the dose to the lowest amount that keeps your levels stable.
Before you start taking methimazole, you’ll have blood work done to check your white blood cell count and liver function. These serve as a baseline. After starting the medication, your thyroid hormone levels are typically checked at four weeks, then every four to eight weeks until they stabilize, and every three months after that. Routine white blood cell monitoring isn’t necessary unless you develop specific symptoms (more on that below).
Some people take methimazole for 12 to 18 months and then stop, hoping for remission. Others need it long-term or use it as a bridge to more definitive treatment like surgery or radioactive iodine.
Methimazole and Pregnancy
Methimazole carries a known risk of birth defects when taken during the first trimester. Babies exposed to it early in pregnancy have more frequent and more severe birth defects compared to the alternative antithyroid drug, propylthiouracil (PTU). For this reason, the American Thyroid Association recommends that women with hyperthyroidism use PTU during the first trimester instead.
The situation reverses after the first trimester. PTU carries a risk of serious liver damage, while methimazole does not. Current guidelines recommend switching back to methimazole by the second trimester to protect the mother’s liver while continuing to manage thyroid levels for the remainder of pregnancy.
Potential Side Effects
Most people tolerate methimazole well. Common side effects include mild joint pain, nausea, skin rash, and temporary hair thinning. These are usually manageable and sometimes improve as your body adjusts to the medication.
Agranulocytosis
The most serious risk is agranulocytosis, a sudden and dangerous drop in white blood cells that leaves you vulnerable to severe infections. This is rare, occurring in roughly 0.1% to 0.5% of patients. The warning signs are a sudden sore throat and high fever. If you develop these symptoms while taking methimazole, you need a white blood cell count checked immediately. Catching it early is critical because stopping the drug promptly allows white blood cell counts to recover.
Liver Effects
Methimazole can occasionally affect the liver, typically causing a pattern of bile flow disruption rather than direct liver cell damage. This is an important distinction from PTU, which has been linked to liver failure, liver transplantation, and death in both adults and children. No cases of liver failure have been reported with methimazole in pediatric patients, which is one reason it’s generally preferred over PTU outside of early pregnancy.
Signs of liver problems include yellowing of the skin or eyes, dark urine, persistent nausea, or upper abdominal pain. Your baseline liver function tests before starting treatment give your doctor a reference point to compare against if these symptoms appear.
Methimazole vs. Propylthiouracil
Methimazole and PTU are the two antithyroid drugs available, and they work through similar mechanisms. Methimazole is preferred in almost all situations for several practical reasons: it can be taken once daily (PTU requires multiple doses), it works more reliably, and it has a significantly better liver safety profile. PTU’s main advantage is its safer use during the first trimester of pregnancy. Outside of that specific window, methimazole is the standard choice for treating hyperthyroidism.